Management of patients with fibrosing interstitial lung diseases

PURPOSE: This article summarizes the appropriate use and pharmacology of treatments for fibrosing interstitial lung diseases, with a specific focus on the antifibrotic agents nintedanib and pirfenidone. SUMMARY: The interstitial lung diseases are a heterogenous group of parenchymal lung disorders wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Lee E, Hilleman, Daniel, Malesker, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881211/
https://www.ncbi.nlm.nih.gov/pubmed/34608488
http://dx.doi.org/10.1093/ajhp/zxab375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881211/
https://www.ncbi.nlm.nih.gov/pubmed/34608488
http://dx.doi.org/10.1093/ajhp/zxab375

Ejemplares similares